Disease/Infection News

RSS

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

In this Journal Sentinel Online opinion piece, Thomas Inglesby, chief executive officer and director of the Center for Biosecurity of UPMC in Baltimore; Anita Cicero, chief operating officer and deputy director of the center; and D.A. Henderson, a distinguished scholar at the center, comment on a recent announcement by scientists that they have genetically modified a strain of H5N1 bird flu that is "capable of spreading through the air between ferrets that were physically separated from each other," indicating "it would be readily transmissible by air between humans."

19 Jan 2012

NGOs in Balkan countries to establish regional body to fight HIV/AIDS stigma, discrimination

Agence France-Presse reports that a group of non-governmental organizations (NGOs) is working to establish a regional association to combat HIV/AIDS stigma and discrimination that is prevalent in the Balkan countries.

19 Jan 2012

USAID's worldwide polio eradication coordinator addresses India's polio progress, global efforts

GlobalPost's "Global Pulse" blog interviews Ellyn Ogden, USAID's worldwide polio eradication coordinator since 1997, about India's progress in eradicating polio as it marked one year without a confirmed case and discusses what the overall eradication fight looks like today.

19 Jan 2012

New combo drug helps suppress hepatitis C genotype 1 infection

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

19 Jan 2012

PfSET10 molecule plays a crucial role in malaria infection

The discovery by researchers from the Walter and Eliza Hall Institute of a molecule that is key to malaria's 'invisibility cloak' will help to better understand how the parasite causes disease and escapes from the defenses mounted by the immune system.

19 Jan 2012

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.

19 Jan 2012

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12.

19 Jan 2012

Scientists crack genetic code for Schistosoma haematobium

Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa.

19 Jan 2012

Bristol-Myers Squibb agrees purchase of Inhibitex for $2.5Bn

American pharmaceutical giant Bristol-Myers Squibb has agreed the purchase of US biotech company Inhibitex, in a $2.5Bn (£1.6bn) deal which includes the promising new anti-hepatitis C drug INX-189, first designed and prepared in Cardiff University.

19 Jan 2012

TB associated with EGFR mutations in patients with lung adenocarcinoma

Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease have not been extensively reported.

19 Jan 2012

Alpha-hemolysin may play an unexpected role in UTIs

Researchers from the University of Utah have identified a process by which the most common types of urinary tract infection-causing bacteria are able to trigger bladder cell shedding and disable immune responses. According to this new study, published in the Jan. 19, 2012, issue of Cell Host & Microbe, α-hemolysin, a toxin secreted by many strains of Escherichia coli (E. coli), may play an important, unexpected role during both the establishment and persistence of urinary tract infections.

19 Jan 2012

Counterfeit malaria drugs endanger millions of lives

According to researchers fake and poor quality anti-malarial drugs are threatening efforts to control the disease in Africa and could put millions of lives at risk. These counterfeit medicines could harm patients and promote drug resistance among malaria parasites, warns the study, funded by the Wellcome Trust.

18 Jan 2012

Indian, WHO officials to meet to discuss managing cases of highly drug-resistant TB

Health officials from India and the WHO are scheduled to meet in Mumbai on Tuesday to discuss how to manage the cases of at least 12 patients infected with a highly drug-resistant tuberculosis (TB) strain, Bloomberg reports (Narayan, 1/17).

18 Jan 2012

Global Fund executive director urges Ukraine to step up efforts to fight HIV/AIDS

Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday "urged Ukraine to step up its efforts to fight the HIV/AIDS epidemic," calling "on the Ukrainian authorities to expand opiate substitution therapy, ensure HIV/AIDS treatment in prison and increase government funding of anti-AIDS programs," the Associated Press reports.

18 Jan 2012

WHO to take lead role in addressing controversial bird flu research, official says

"The World Health Organization says it will take a role in helping sort through an international scientific controversy over two bird flu studies that the U.S. government deemed too dangerous to publish in full," the Canadian Press/Winnipeg Free Press reports.

18 Jan 2012

Researchers to anticipate and track risk for infectious disease outbreak at London Olympics

A research team led by St. Michael's Hospital's Dr. Kamran Khan is teaming up with British authorities to anticipate and track the risk for an infectious disease outbreak at the London Olympics this summer.

18 Jan 2012

Paragon receives JVAP-CBMS contract from DoD

Paragon Bioservices, Inc., a Baltimore-based CMO focused on the process development and manufacturing of biologics, announced today that it has been awarded a JVAP-CBMS contract from the Department of Defense (DoD) for the vaccine development and subsequent GMP manufacturing of the "VEE Replicon Particle Trivalent Filovirus Vaccine."

18 Jan 2012

Study examines effect of MELD score-based allocation on post-liver transplant kidney failure

Research from the University of Michigan Health System shows the risk for kidney failure among liver transplant recipients is higher following the implementation of Model of End Stage Liver Disease (MELD), a policy change in 2002 that altered how liver transplant allocation is decided.

18 Jan 2012

WHO's Chan urges new approach to preventing, fighting diseases at Executive Board meeting

"Countries need to change their current mindset to successfully tackle non-communicable diseases (NCDs), the head of the United Nations World Health Organization (WHO) said Monday, adding that governments will need to explore new approaches to prevent and treat these diseases, which have quickly become one of the most pressing issues in public health," the U.N. News Centre reports.

18 Jan 2012

India applauded for marking one year without polio, but urged to also focus on other diseases

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Victoria Fan, a research fellow at CGD, and Rachel Silverman, a research assistant at the center, respond to India's marking of one-year since a case of polio was found in the country, writing, "While we applaud India for its commitment to reaching this milestone, let us not allow this recent success obscure the sorry state of vaccination in India."

18 Jan 2012

Disease/Infection News

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

NGOs in Balkan countries to establish regional body to fight HIV/AIDS stigma, discrimination

USAID's worldwide polio eradication coordinator addresses India's polio progress, global efforts

New combo drug helps suppress hepatitis C genotype 1 infection

PfSET10 molecule plays a crucial role in malaria infection

Soligenix reports results from long-term stability studies of SGX204 anthrax vaccine

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Scientists crack genetic code for Schistosoma haematobium

Bristol-Myers Squibb agrees purchase of Inhibitex for $2.5Bn

TB associated with EGFR mutations in patients with lung adenocarcinoma

Alpha-hemolysin may play an unexpected role in UTIs

Counterfeit malaria drugs endanger millions of lives

Indian, WHO officials to meet to discuss managing cases of highly drug-resistant TB

Global Fund executive director urges Ukraine to step up efforts to fight HIV/AIDS

WHO to take lead role in addressing controversial bird flu research, official says

Researchers to anticipate and track risk for infectious disease outbreak at London Olympics

Paragon receives JVAP-CBMS contract from DoD

Study examines effect of MELD score-based allocation on post-liver transplant kidney failure

WHO's Chan urges new approach to preventing, fighting diseases at Executive Board meeting

India applauded for marking one year without polio, but urged to also focus on other diseases

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News